Topic Highlight
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2006; 12(22): 3537-3545
Published online Jun 14, 2006. doi: 10.3748/wjg.v12.i22.3537
Figure 1
Figure 1 Additive effect of estrogens (EE) and insulin like growth factor-1 (IGF1) in the modulation of cholangiocyte proliferation. EE and IGF1 play additive effects on cholangiocyte proliferation by acting at both receptor and post-receptor levels IGF1 and EE induce, in cholangiocytes, additive increase of phosphorylated ERK1/2.
Figure 2
Figure 2 Immunohistochemistry of ER-α and ER-β in cholangiocytes in different human pathologies, bP < 0. 01 , dP < 0.01 vs other columns.
Figure 3
Figure 3 Immunohistochemistry for ER-α and ER-β. Biopsies of human primary biliary cirrhosis showing an intense positivity for both ER-α and ER-β in the proliferating bile ducts. Orig. magn., x 20.
Figure 4
Figure 4 Immunohistochemistry for ER-α and ER-β. Biopsies of human cholangiocarcinoma showing an intense positivity for both ER-α and ER-β. Orig. magn., x 20.